p.65 抽出テキスト

Lawton et al 2021 ACC/AHA/SCAI Coronary Revascularization Guideline

January 18, 2022 Circulation. 2022;145:e18–e114. DOI: 10.1161/CIR.0000000000001038 e82

CLINICAL STATEMENTS AND GUIDELINES 24 van Diepen S, Katz JN, Albert NM, et al. Contemporary management of car-

diogenic shock: a scientific statement from the American Heart Association. Circulation. 2017;136:e232–e268. 25.	 Kulik A, Ruel M, Jneid H, et al. Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association. Circulation. 2015;131:927–964. 26.	 American Diabetes Association. 8. Pharmacologic approaches to glycemic

treatment: standards of medical care in diabetes—2018. Diabetes Care. 2018;41:S73–S85.

1.5 Class of Recommendation and Level of Evidence

1 ACCF/AHA Task Force on Practice Guidelines. Methodology Manual and

Policies From the ACCF/AHA Task Force on Practice Guidelines. American College of Cardiology and American Heart Association. 2010. Accessed April 12, 2021. Available at: https://www.acc.org/Guidelines/About-Guidelines-and-Clinical-Documents/Methodology and https://professional.heart. org/-/media/phd-files/guidelines-and-statements/methodology_manual_ and_policies_ucm_319826.pdf

2.1 Improving Equity of Care in Revascularization

1 O’Donoghue M, Boden WE, Braunwald E, et al. Early invasive vs conser-

vative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. JAMA. 2008;300:71–80. 2.	 Lee LC, Poh KK, Tang TPL, et al. The impact of gender on the outcomes of invasive versus conservative management of patients with non-ST-segment elevation myocardial infarction. Ann Acad Med Singap. 2010;39:168–172. 3.	 Tamis-Holland JE, Palazzo A, Stebbins AL, et al. Benefits of direct angioplasty for women and men with acute myocardial infarction: results of the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes Angioplasty (GUSTO II-B) Angioplasty Substudy. Am Heart J. 2004;147:133–139. 4.	 Heer T, Hochadel M, Schmidt K, et al. Sex differences in percutaneous coronary intervention-insights from the coronary angiography and PCI registry of the German Society of Cardiology. J Am Heart Assoc. 2017;6: e004972. 5.	 Tamis-Holland JE, Lu J, Korytkowski M, et al. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes). J Am Coll Cardiol. 2013;61:1767– 1776. 6.	 Davis KB, Chaitman B, Ryan T, et al. Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: a CASS registry study. Coronary Artery Surgery Study. J Am Coll Cardiol. 1995;25:1000–1009. 7.	 Gudnadottir GS, Andersen K, Thrainsdottir IS, et al. Gender differences in coronary angiography, subsequent interventions, and outcomes among patients with acute coronary syndromes. Am Heart J. 2017;191:65–74. 8.	 Golomb M, Redfors B, Crowley A, et al. Prognostic impact of race in patients undergoing PCI: analysis from 10 randomized coronary stent trials. JACC Cardiovasc Interv. 2020;13:1586–1595. 9.	 Palmeri ST, Lowe AM, Sleeper LA, et al. Racial and ethnic differences in the treatment and outcome of cardiogenic shock following acute myocardial infarction. Am J Cardiol. 2005;96:1042–1049. 10.	 Sabatine MS, Blake GJ, Drazner MH, et al. Influence of race on death and ischemic complications in patients with non-ST-elevation acute coronary syndromes despite modern, protocol-guided treatment. Circulation. 2005;111:1217–1224. 11.	 Cantor JC, DeLia D, Tiedemann A, et al. Reducing racial disparities in coronary angiography. Health Aff (Millwood). 2009;28:1521–1531. 12.	 Miller CD, Stopyra JP, Mahler SA, et al. ACES (Accelerated Chest Pain Evaluation With Stress Imaging) protocols eliminate testing disparities in patients with chest pain. Crit Pathw Cardiol. 2019;18:5–9. 13.	 Rashid M, Fischman DL, Martinez SC, et al. Temporal trends and predictors of time to coronary angiography following non-ST-elevation acute coronary syndrome in the USA. Coron Artery Dis. 2019;30:159–170. 14.	 Zhao M, Woodward M, Vaartjes I, et al. Sex differences in cardiovascular medication prescription in primary care: a systematic review and meta-analysis. J Am Heart Assoc. 2020;9: e014742. 15.	 Arora S, Stouffer GA, Kucharska-Newton A, et al. Fifteen-year trends in

management and outcomes of non-ST-segment-elevation myocardial in- farction among black and white patients: the ARIC community surveillance study, 2000-2014. J Am Heart Assoc. 2018;7:e010203. 16.	 Havranek EP, Mujahid MS, Barr DA, et al. Social determinants of risk and

outcomes for cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2015;132:873–898. 17.	 Walli-Attaei M, Joseph P, Rosengren A, et al. Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020;396:97–109. 18.	 Backholer K, Peters SAE, Bots SH, et al. Sex differences in the relationship between socioeconomic status and cardiovascular disease: a systematic review and meta-analysis. J Epidemiol Community Health. 2017;71:550–557. 19.	 Malambo P, Kengne AP, De Villiers A, et al. Built environment, selected risk factors and major cardiovascular disease outcomes: a systematic review. PLoS One. 2016;11: e0166846. 20.	 Carnethon MR, Pu J, Howard G, et al. Cardiovascular health in African Americans: a scientific statement from the American Heart Association. Circulation. 2017;136:e393–e423. 21.	 Volgman AS, Palaniappan LS, Aggarwal NT, et al. Atherosclerotic cardiovascular disease in South Asians in the United States: epidemiology, risk factors, and treatments: a scientific statement from the American Heart Association. Circulation. 2018;138:e1–e34. 22.	 Rodriguez CJ, Allison M, Daviglus ML, et al. Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association. Circulation. 2014;130:593–625. 23.	 Beohar N, Davidson CJ, Massaro EM, et al. The impact of race/ethnicity on baseline characteristics and the burden of coronary atherosclerosis in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. Am Heart J. 2011;161:755–763. 24.	 Mehran R, Chandrasekhar J, Davis S, et al. Impact of race and ethnicity on the clinical and angiographic characteristics, social determinants of health, and 1-year outcomes after everolimus-eluting coronary stent procedures in women. Circ Cardiovasc Interv. 2019;12:e006918. 25.	 Feinstein M, Ning H, Kang J, et al. Racial differences in risks for first cardiovascular events and noncardiovascular death: the Atherosclerosis Risk in Communities study, the Cardiovascular Health Study, and the Multi-Ethnic Study of Atherosclerosis. Circulation. 2012;126:50–59. 26.	 Pursnani S, Merchant M. South Asian ethnicity as a risk factor for coronary heart disease. Atherosclerosis. 2020;315:126–130. 27.	 Sonel AF, Good CB, Mulgund J, et al. Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines?). Circulation. 2005;111:1225–1232. 28.	 Pearte CA, Myerson M, Coresh J, et al. Variation and temporal trends in the use of diagnostic testing during hospitalization for acute myocardial infarction by age, gender, race, and geography (the Atherosclerosis Risk In Communities Study). Am J Cardiol. 2008;101:1219–1225. 29.	 Freund KM, Jacobs AK, Pechacek JA, et al. Disparities by race, ethnicity, and sex in treating acute coronary syndromes. J Womens Health (Larchmt). 2012;21:126–132. 30.	 Vaccarino V, Rathore SS, Wenger NK, et al. Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med. 2005;353:671–682. 31.	 Cenko E, Yoon J, Kedev S, et al. Sex differences in outcomes after ­STEMI: effect modification by treatment strategy and age. JAMA Intern Med. 2018;178:632–639. 32.	 Blomkalns AL, Chen AY, Hochman JS, et al. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol. 2005;45:832–837. 33.	 Asleh R, Manemann SM, Weston SA, et al. Sex differences in outcomes after myocardial infarction in the community. Am J Med. 2021;134:114–121. 34.	 Iantorno M, Rogers T, Torguson R, et al. Racial disparities in clinical characteristics and outcomes of women undergoing percutaneous coronary intervention. Cardiovasc Revasc Med. 2019;20:1039–1042. 35.	 Hravnak M, Whittle J, Kelley ME, et al. Symptom expression in coronary heart disease and revascularization recommendations for black and white patients. Am J Public Health. 2007;97:1701–1708. 36.	 Mirvis DM, Graney MJ. Impact of race and age on the effects of regionaliza-

tion of cardiac procedures in the Department of Veterans Affairs health care system. Am J Cardiol. 1998;81:982–987.

Downloaded from http://ahajournals.org by on October 7, 2026